The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation• Stanford’s AI Designed Bacteriophages: Ushering in the Next Phase in IP Strategy for Phage Companies?• Breathing Engineered Bacteria: A New Approach to Treating Lung Disease• Vedanta Biosciences Secures $60 Million in Funding Ahead of Pivotal Phase 3 Data• Gut fungi may hold the key to treating Asthma worldwide•

Category: Gastrointestinal

Microba Delivers Landmark IBD Results & Signs Major Gastro Partner
Finance

Microba Delivers Landmark IBD Results & Signs Major Gastro Partner

APR 29, 2025
Scientists find gut-brain link that may affect behavior in children with autism
Gastrointestinal

Scientists find gut-brain link that may affect behavior in children with autism

APR 25, 2025
Possible colon cancer vaccine target uncovered in bacteria
Gastrointestinal

Possible colon cancer vaccine target uncovered in bacteria

DEC 12, 2024
Researchers hope to develop novel drugs for gastrointestinal disorders by fermenting feces
Gastrointestinal

Researchers hope to develop novel drugs for gastrointestinal disorders by fermenting feces

NOV 7, 2024
EUDRACAP® colon functional capsules for ileo-colonic delivery: Formulating the next generation of live biotherapeutic products
Gastrointestinal

EUDRACAP® colon functional capsules for ileo-colonic delivery: Formulating the next generation of live biotherapeutic products

OCT 1, 2024
ProDigest Awarded FDA Contract to Provide a Preclinical Gastrointestinal Model: SHIME®
Gastrointestinal

ProDigest Awarded FDA Contract to Provide a Preclinical Gastrointestinal Model: SHIME®

SEP 16, 2024
Researchers develop probiotic to ameliorate ulcerative colitis
Biotics and Supplements

Researchers develop probiotic to ameliorate ulcerative colitis

SEP 1, 2024
AI-Powered Precision Nutrition Plan by Enbiosis Improves IBS symptoms compared to low FODMAP diet
Gastrointestinal

AI-Powered Precision Nutrition Plan by Enbiosis Improves IBS symptoms compared to low FODMAP diet

MAY 29, 2024
EnteroBiotix Completes £27m Financing Round & Initiates Phase 2 Study in Patients with IBS
Clinical & Manufacturing

EnteroBiotix Completes £27m Financing Round & Initiates Phase 2 Study in Patients with IBS

APR 4, 2024
Bacteria subtype linked to growth in up to 50% of human colorectal cancers
Gastrointestinal

Bacteria subtype linked to growth in up to 50% of human colorectal cancers

MAR 26, 2024
Canada approves gut-brain axis health claims for Chr. Hansen probiotic strain
Biotics and Supplements

Canada approves gut-brain axis health claims for Chr. Hansen probiotic strain

NOV 8, 2023